SCHEMBL24766041

SCHEMBL24766041

C[C@H](CCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OSBP P22059 1/20 0.90
▸ OSBP2 Q969R2 1/20 0.90
▸ GPBAR1 Q8TDU6 8/20 0.70
▸ EPHA2 P29317 4/20 0.70
▸ CASP7 P55210 3/20 0.70
▸ HIF1A Q16665 3/20 0.70
▸ VDR P11473 3/20 0.70
▸ TP53 P04637 2/20 0.70
▸ MAPK1 P28482 2/20 0.70
▸ HSD17B10 Q99714 2/20 0.70
▸ BLM P54132 2/20 0.70
▸ TDP1 Q9NUW8 2/20 0.70
▸ USP2 O75604 2/20 0.70
▸ LMNA P02545 2/20 0.70
▸ CYP3A4 P08684 2/20 0.70
▸ MDM4 O15151 1/20 0.70
▸ MAPT P10636 1/20 0.70
▸ HSPD1 P10809 1/20 0.70
▸ TSHR P16473 1/20 0.70
▸ PTPN2 P17706 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16786313 1.00 OSBP (0.90) OSBPOSBP2GPBAR1EPHA2CASP7
SCHEMBL14770971 1.00 OSBP (0.90) OSBPOSBP2GPBAR1EPHA2CASP7
SCHEMBL23373110 1.00 OSBP (0.90) OSBPOSBP2GPBAR1EPHA2CASP7
SCHEMBL31145625 1.00 OSBP (0.90) OSBPOSBP2GPBAR1EPHA2CASP7
SCHEMBL16225856 0.94 OSBP (1.00) OSBPOSBP2GPBAR1EPHA2CASP7
SCHEMBL25335924 0.94 OSBP (1.00) OSBPOSBP2GPBAR1EPHA2CASP7
SCHEMBL8837063 0.94 OSBP (1.00) OSBPOSBP2GPBAR1EPHA2CASP7
SCHEMBL22901717 0.94 OSBP (1.00) OSBPOSBP2GPBAR1EPHA2CASP7
SCHEMBL22901777 0.94 OSBP (1.00) OSBPOSBP2GPBAR1EPHA2CASP7
SCHEMBL11528869 0.94 OSBP (1.00) OSBPOSBP2GPBAR1EPHA2CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402965-A1 STEROL ANALOGS AND USES THEREOF ARES CAPITAL CORPORATION, AS AGENT 2022-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402965-A1 STEROL ANALOGS AND USES THEREOF NPC1L1, NPC1, SREBF2 OSBP 74/4885OSBP2 86/4885GPBAR1 309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback